Pearls & Oy-sters: When Genetic Generalized Epilepsy Becomes Progressive

Neurology. 2021 Mar 2;96(9):454-457. doi: 10.1212/WNL.0000000000011293. Epub 2020 Dec 4.

Authors

Priya Purushothaman¹, Erin M McGinnis¹, Monica Aldulescu¹, Cynthia V Stack¹, Tracy S Gertler²

Affiliations

¹ From the Division of Pediatric Neurology (P.P., E.M.M., C.V.S., T.S.G.) and Department of Pathology (M.A.), Ann and Robert H. Lurie Children's Hospital of Chicago, IL.
² From the Division of Pediatric Neurology (P.P., E.M.M., C.V.S., T.S.G.) and Department of Pathology (M.A.), Ann and Robert H. Lurie Children's Hospital of Chicago, IL. tgertler@luriechildrens.org.

No abstract available

Publication types

Case Reports
Research Support, N.I.H., Extramural

MeSH terms

Adolescent
Anticonvulsants / therapeutic use
Disease Progression
Drug Resistant Epilepsy / genetics
Drug Resistant Epilepsy / physiopathology
Electroencephalography
Epilepsy, Generalized / etiology
Female
Humans
Lafora Disease / drug therapy
Lafora Disease / genetics*
Lafora Disease / physiopathology
Protein Tyrosine Phosphatases, Non-Receptor / genetics

Substances

Anticonvulsants
Protein Tyrosine Phosphatases, Non-Receptor
EPM2A protein, human

Grants and funding

K08 NS104237/NS/NINDS NIH HHS/United States